HRP20040622A2 - Method of obtaining citalopram - Google Patents
Method of obtaining citalopram Download PDFInfo
- Publication number
- HRP20040622A2 HRP20040622A2 HR20040622A HRP20040622A HRP20040622A2 HR P20040622 A2 HRP20040622 A2 HR P20040622A2 HR 20040622 A HR20040622 A HR 20040622A HR P20040622 A HRP20040622 A HR P20040622A HR P20040622 A2 HRP20040622 A2 HR P20040622A2
- Authority
- HR
- Croatia
- Prior art keywords
- citalopram
- water
- aqueous phase
- temperature
- toluene
- Prior art date
Links
- WSEQXVZVJXJVFP-HXUWFJFHSA-N (R)-citalopram Chemical compound C1([C@@]2(C3=CC=C(C=C3CO2)C#N)CCCN(C)C)=CC=C(F)C=C1 WSEQXVZVJXJVFP-HXUWFJFHSA-N 0.000 title claims description 85
- 229960001653 citalopram Drugs 0.000 title claims description 83
- 238000000034 method Methods 0.000 title claims description 30
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- 239000008346 aqueous phase Substances 0.000 claims description 22
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 20
- 239000012535 impurity Substances 0.000 claims description 19
- 239000003960 organic solvent Substances 0.000 claims description 19
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 16
- 238000006243 chemical reaction Methods 0.000 claims description 14
- ROSDSFDQCJNGOL-UHFFFAOYSA-N protonated dimethyl amine Natural products CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 claims description 14
- 150000001875 compounds Chemical class 0.000 claims description 13
- 238000000746 purification Methods 0.000 claims description 11
- 150000003839 salts Chemical class 0.000 claims description 11
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 9
- 238000000605 extraction Methods 0.000 claims description 7
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 6
- DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 239000008096 xylene Substances 0.000 claims description 6
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 5
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 1
- 229910052802 copper Inorganic materials 0.000 claims 1
- 239000010949 copper Substances 0.000 claims 1
- 125000003944 tolyl group Chemical group 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 239000000758 substrate Substances 0.000 description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 239000002243 precursor Substances 0.000 description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- WIHMBLDNRMIGDW-UHFFFAOYSA-N 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3h-2-benzofuran-5-carbonitrile;hydron;bromide Chemical compound [Br-].O1CC2=CC(C#N)=CC=C2C1(CCC[NH+](C)C)C1=CC=C(F)C=C1 WIHMBLDNRMIGDW-UHFFFAOYSA-N 0.000 description 3
- PTJADDMMFYXMMG-UHFFFAOYSA-N Demethylcitalopram Chemical compound O1CC2=CC(C#N)=CC=C2C1(CCCNC)C1=CC=C(F)C=C1 PTJADDMMFYXMMG-UHFFFAOYSA-N 0.000 description 3
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 229960000584 citalopram hydrobromide Drugs 0.000 description 3
- 239000000539 dimer Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 150000002825 nitriles Chemical group 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- -1 Pd2(dba)3 Substances 0.000 description 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000012485 toluene extract Substances 0.000 description 2
- UXGVMFHEKMGWMA-UHFFFAOYSA-N 2-benzofuran Chemical group C1=CC=CC2=COC=C21 UXGVMFHEKMGWMA-UHFFFAOYSA-N 0.000 description 1
- WOLPGGGWZDXCNM-UHFFFAOYSA-N 3-[5-bromo-1-(4-fluorophenyl)-3h-2-benzofuran-1-yl]-n,n-dimethylpropan-1-amine Chemical compound O1CC2=CC(Br)=CC=C2C1(CCCN(C)C)C1=CC=C(F)C=C1 WOLPGGGWZDXCNM-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- IUSPXLCLQIZFHL-UHFFFAOYSA-N 5-bromo-3h-2-benzofuran-1-one Chemical compound BrC1=CC=C2C(=O)OCC2=C1 IUSPXLCLQIZFHL-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- NFHFRUOZVGFOOS-UHFFFAOYSA-N Pd(PPh3)4 Substances [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 238000010420 art technique Methods 0.000 description 1
- IANQTJSKSUMEQM-UHFFFAOYSA-N benzofuran Natural products C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000017858 demethylation Effects 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- WXHIJDCHNDBCNY-UHFFFAOYSA-N palladium dihydride Chemical compound [PdH2] WXHIJDCHNDBCNY-UHFFFAOYSA-N 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- MNWBNISUBARLIT-UHFFFAOYSA-N sodium cyanide Chemical compound [Na+].N#[C-] MNWBNISUBARLIT-UHFFFAOYSA-N 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200200167A ES2194597B2 (es) | 2002-01-25 | 2002-01-25 | Procedimiento para la obtencion de citalopram. |
PCT/ES2003/000037 WO2003062218A1 (es) | 2002-01-25 | 2003-01-24 | Procedimiento para la obtención de citalopram |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20040622A2 true HRP20040622A2 (en) | 2005-04-30 |
Family
ID=27589316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20040622A HRP20040622A2 (en) | 2002-01-25 | 2004-07-08 | Method of obtaining citalopram |
Country Status (13)
Country | Link |
---|---|
US (1) | US6635773B2 (ja) |
EP (1) | EP1479673A1 (ja) |
JP (1) | JP2005522419A (ja) |
CN (1) | CN1688565A (ja) |
CA (1) | CA2474323A1 (ja) |
ES (1) | ES2194597B2 (ja) |
HR (1) | HRP20040622A2 (ja) |
IL (1) | IL162848A0 (ja) |
MX (1) | MXPA04007156A (ja) |
NO (1) | NO20043568D0 (ja) |
PL (1) | PL371199A1 (ja) |
WO (1) | WO2003062218A1 (ja) |
ZA (1) | ZA200405441B (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003222435A1 (en) * | 2002-01-07 | 2003-07-24 | Sun Pharmaceutical Industries Limited | Process for the preparation of 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile |
GB0204607D0 (en) * | 2002-02-27 | 2002-04-10 | Matrix Lab Ltd | Process |
TR200504022T1 (tr) * | 2003-03-24 | 2006-08-21 | Hetero Drugs Limited | (S)-sitalopram oksalatın yeni sıvı kristal formları. |
GB0317475D0 (en) * | 2003-07-25 | 2003-08-27 | Meditab Specialities Pvt Ltd | Product |
US20050143350A1 (en) * | 2003-11-19 | 2005-06-30 | Seed John C. | Combination drug therapy to treat obesity |
TWI339651B (en) * | 2004-02-12 | 2011-04-01 | Lundbeck & Co As H | Method for the separation of intermediates which may be used for the preparation of escitalopram |
CN111533662B (zh) * | 2020-04-07 | 2022-08-23 | 福建海西新药创制有限公司 | 一种西酞普兰中间体的合成方法 |
CN114763343A (zh) * | 2021-01-14 | 2022-07-19 | 浙江华海药业股份有限公司 | 一种西酞普兰或s-西酞普兰的纯化方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1181272E (pt) * | 2000-12-28 | 2003-01-31 | Lundbeck & Co As H | Processo para a preparacao de citalopram puro |
GB0105627D0 (en) * | 2001-03-07 | 2001-04-25 | Cipla Ltd | Preparation of phthalanes |
GB2376945A (en) * | 2001-06-27 | 2002-12-31 | Cipla Ltd | Citalopram preparation |
GB0204607D0 (en) * | 2002-02-27 | 2002-04-10 | Matrix Lab Ltd | Process |
-
2002
- 2002-01-25 ES ES200200167A patent/ES2194597B2/es not_active Expired - Fee Related
-
2003
- 2003-01-24 IL IL16284803A patent/IL162848A0/xx unknown
- 2003-01-24 JP JP2003562097A patent/JP2005522419A/ja active Pending
- 2003-01-24 CN CN03802625.2A patent/CN1688565A/zh active Pending
- 2003-01-24 PL PL03371199A patent/PL371199A1/xx unknown
- 2003-01-24 MX MXPA04007156A patent/MXPA04007156A/es unknown
- 2003-01-24 EP EP03706634A patent/EP1479673A1/en not_active Withdrawn
- 2003-01-24 US US10/351,289 patent/US6635773B2/en not_active Expired - Fee Related
- 2003-01-24 CA CA002474323A patent/CA2474323A1/en not_active Abandoned
- 2003-01-24 WO PCT/ES2003/000037 patent/WO2003062218A1/es not_active Application Discontinuation
-
2004
- 2004-07-08 ZA ZA200405441A patent/ZA200405441B/en unknown
- 2004-07-08 HR HR20040622A patent/HRP20040622A2/hr not_active Application Discontinuation
- 2004-08-25 NO NO20043568A patent/NO20043568D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20030144534A1 (en) | 2003-07-31 |
PL371199A1 (en) | 2005-06-13 |
ES2194597B2 (es) | 2004-08-01 |
US6635773B2 (en) | 2003-10-21 |
NO20043568L (no) | 2004-08-25 |
ES2194597A1 (es) | 2003-11-16 |
NO20043568D0 (no) | 2004-08-25 |
JP2005522419A (ja) | 2005-07-28 |
CN1688565A (zh) | 2005-10-26 |
CA2474323A1 (en) | 2003-07-31 |
IL162848A0 (en) | 2005-11-20 |
EP1479673A1 (en) | 2004-11-24 |
MXPA04007156A (es) | 2004-10-29 |
WO2003062218A1 (es) | 2003-07-31 |
ZA200405441B (en) | 2005-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CZ295477B6 (cs) | Způsob přípravy tolterodinu | |
EP1499583A1 (en) | Process for preparing highly functionalized y-butyrolactams and y-amino acids | |
SE517623C2 (sv) | Förfarande för framställning av ren citalopram | |
HRP20040622A2 (en) | Method of obtaining citalopram | |
JP2005507900A (ja) | シタロプラムの製造方法 | |
KR100653141B1 (ko) | 시탈로프람의 제조 방법 | |
HRP20050893A2 (en) | Process for the preparation of a cyano-isobenzofuran | |
CN103183673A (zh) | (s,s)-2,8-二氮杂双环[4,3,0]壬烷的合成方法 | |
CN107814757B (zh) | 一种合成多取代吡咯衍生物的方法 | |
JP4102465B2 (ja) | ベンゾフェノンイミン反応器流出液から水およびアンモニアを除去する方法 | |
CA2454335A1 (en) | Process for the preparation of citalopram hydrobromide | |
US6781003B1 (en) | Preparation of pure citalopram | |
WO2011027323A1 (en) | Process for the preparation of ramelteon | |
CN108164498A (zh) | 一种黄连素及多巴胺中间体胡椒乙胺的制备方法 | |
JP4664903B2 (ja) | 4,10β−ジアセトキシ−2α−ベンゾイルオキシ−5β,20−エポキシ−1,13α−ジヒドロキシ−9−オキソ−19−ノルシクロプロパ[g]タキサ−11−エンの製造方法 | |
EP1478638B1 (en) | Purification of citalopram | |
JP4480802B2 (ja) | 臭素化剤 | |
WO2023100110A1 (en) | Process for preparing brivaracetam | |
AU2003278409A1 (en) | Improved process for the manufacture of citalopram hydrobromide | |
CN117447334A (zh) | 一种高效地合成α-氨基缩醛的方法 | |
JPS60243066A (ja) | インドリン類の工業的製造方法 | |
JP2005255610A (ja) | 光学活性な3−アミノアスパラギン酸誘導体の製造方法 | |
CN1496358A (zh) | 制备西酞普兰的方法 | |
JP2002308842A (ja) | エナミド及び光学活性アミン誘導体の製造方法 | |
JPS638949B2 (ja) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20050217 Year of fee payment: 3 |
|
A1OB | Publication of a patent application | ||
OBST | Application withdrawn |